Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The influenza vaccine licensing process.

J M Wood1, R A Levandowski

  • 1National Institute for Biological Standards and Control, Blanche Lane, South Mimms, EN6 3QG, Hertfordshire, Potters Bar, UK. jwood@nibsc.ac.uk

Vaccine
|April 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What factors are associated with food security among recently arrived refugees resettling in high-income countries? A scoping review.

Public health nutrition·2021
Same author

The effects of auditory satellite navigation instructions and visual blur on road hazard perception.

Accident; analysis and prevention·2019
Same author

Does gene expression in laryngeal subsites differ between patients with laryngopharyngeal reflux and controls?

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2017
Same author

Eosinophilic oesophagitis: an otolaryngologist's perspective.

British journal of hospital medicine (London, England : 2005)·2017
Same author

Therapeutic potential of NADPH oxidase 1/4 inhibitors.

British journal of pharmacology·2016
Same author

The Scientific Status of Projective Techniques.

Psychological science in the public interest : a journal of the American Psychological Society·2015

Influenza vaccines undergo a unique annual update process for strain selection. Regulatory pathways in the EU and USA are examined, highlighting the need for pandemic-ready vaccine licensing.

Area of Science:

  • Vaccinology
  • Immunology
  • Public Health

Background:

  • Influenza vaccines require annual strain updates due to viral evolution.
  • Existing licensing processes must accommodate rapid vaccine adjustments.
  • Global influenza surveillance informs vaccine composition.

Purpose of the Study:

  • To describe the unique licensing procedures for influenza vaccines.
  • To examine the regulatory frameworks in the European Union and USA.
  • To assess the need for adaptable licensing during influenza pandemics.

Main Methods:

  • Review of regulatory guidelines for influenza vaccine licensing in the EU and USA.
  • Analysis of the annual strain selection and update procedures.
  • Discussion of pandemic preparedness in vaccine regulation.

Related Experiment Videos

Main Results:

  • Influenza vaccine licensing involves a distinct, rapid annual update mechanism.
  • The European Union and USA have established processes for annual influenza vaccine strain changes.
  • Current processes may require adaptation for urgent pandemic vaccine needs.

Conclusions:

  • Influenza vaccine licensing is characterized by its dynamic annual update requirement.
  • Regulatory procedures in major regions facilitate timely vaccine adjustments.
  • Licensing frameworks must be agile to ensure rapid vaccine availability during influenza pandemics.